BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26536993)

  • 1. A case of transcatheter aortic valve implantation complication with total femoral artery thrombosis due to failure of the ProStar device.
    Yüksel İÖ; Köklü E; Arslan Ş; Cağırcı G; Küçükseymen S
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):651-4. PubMed ID: 26536993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early transcatheter aortic valve thrombosis.
    Greason KL; Mathew V; Sarano ME; Maleszewski JJ; Suri RM; Rihal CS
    J Card Surg; 2013 May; 28(3):264-6. PubMed ID: 23551435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
    Sedaghat A; Sinning JM; Werner N
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
    Genereux P; Kodali S; Leon MB; Smith CR; Ben-Gal Y; Kirtane AJ; Daneault B; Reiss GR; Moses JW; Williams MR
    JACC Cardiovasc Interv; 2011 Aug; 4(8):861-7. PubMed ID: 21851899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Frozen" leaflet: a dreadful complication of transcatheter aortic valve implantation.
    Agostoni P; Buijsrogge MP; Stella PR
    Circ Cardiovasc Interv; 2012 Apr; 5(2):321-3. PubMed ID: 22511742
    [No Abstract]   [Full Text] [Related]  

  • 8. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
    Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfemoral aortic valve implantation new criteria to predict vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
    Buchanan GL; Chieffo A; Montorfano M; Maccagni D; Maisano F; Latib A; Covello RD; Grimaldi A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):579-83. PubMed ID: 22511470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2012 Feb; 5(2):207-14. PubMed ID: 22361606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
    Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
    EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transcatheter valve-in-valve implantation in a small deteriorated aortic valve bioprosthesis.
    Bjursten H; Götberg M; Harnek J; Nozohoor S
    J Heart Valve Dis; 2013 May; 22(3):433-5. PubMed ID: 24151773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
    Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal prosthetic mitral valve encroachment during transcatheter aortic valve implantation.
    Acar B; Kuyumcu S; Aydin S; Kara M; Karakurt M; Ozeke O; Demirkan B; Temizhan A; Kisacik HL
    Int J Cardiol; 2015 Mar; 182():235-6. PubMed ID: 25594924
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations.
    Bleiziffer S; Ruge H; Mazzitelli D; Hutter A; Opitz A; Bauernschmitt R; Lange R
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1073-80. PubMed ID: 19765739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose of patients undergoing transcatheter aortic valve implantation: a comparison between Edwards SAPIEN XT and Medtronic CoreValve aortic valve prostheses.
    Steinvil A; Aviram G; Konigstein M; Abramowitz Y; Halkin A; Arbel Y; Ben-Gal Y; Keren G; Banai S; Finkelstein A
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E578-82. PubMed ID: 23592438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up.
    Ussia GP; Barbanti M; Sarkar K; Aruta P; Scarabelli M; Cammalleri V; Immè S; Pistritto AM; Gulino S; Mulè M; Deste W; Cannata S; Tamburino C
    EuroIntervention; 2012 Mar; 7(11):1285-92. PubMed ID: 22433191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.